Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Recruiting 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Melanoma 4Skin Neoplasms 2Dysplastic Nevus Syndrome 2Disease 2Non-melanoma Skin Cancer 1Nevus, Pigmented 1Nevus 1Margins of Excision 1Carcinoma, Basal Cell 1

Interventions

Nivolumab 13Ipilimumab 10pembrolizumab 8cemiplimab 6Surveys and Questionnaires 6Biopsy 6aldesleukin 5Radiotherapy 5Interleukin-2 5Blood Specimen Collection 5Temozolomide 4Sirolimus 4Photochemotherapy 4Mohs Surgery 4HhAntag691 4Fluorouracil 4Educational Status 4Cyclophosphamide 4sonidegib 3fludarabine phosphate 3fludarabine 3avelumab 3Vemurafenib 3Surgical Procedures, Operative 3Radiation 3Petrolatum 3Cetuximab 3Aminolevulinic Acid 3trametinib 2dabrafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Skin Neoplasms × Dermoscopy × Clear all
NCT05321784 2025-12-29

At-Home Dermoscopy Artificial Intelligence

OHSU Knight Cancer Institute

Phase NA Terminated
1 enrolled 5 charts
Dermatologic

Skin Neoplasms

NCT05446155 2024-01-23

BioMEL

Region Skane

Recruiting
2,000 enrolled
Dermatologic

Dysplastic Nevus Syndrome, Melanoma, Nevus, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡